Related references
Note: Only part of the references are listed.Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C
Carolina Scagnolari et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Interferon-λ1 Linked to a Stabilized Dimer of Fab Potently Enhances both Antitumor and Antiviral Activities in Targeted Cells
Donglin Liu et al.
PLOS ONE (2013)
Epithelial Cell Responses to Infection with Human Papillomavirus
Margaret A. Stanley
CLINICAL MICROBIOLOGY REVIEWS (2012)
Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus
Carolina Scagnolari et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2012)
Interferon Lambda: A New Sword in Cancer Immunotherapy
Ahmed Lasfar et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
Human MxA Protein: An Interferon-Induced Dynamin-Like GTPase with Broad Antiviral Activity
Otto Haller et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
High-Risk Human Papillomaviruses Repress Constitutive Kappa Interferon Transcription via E6 To Prevent Pathogen Recognition Receptor and Antiviral-Gene Expression
Jeanette Reiser et al.
JOURNAL OF VIROLOGY (2011)
Interferon-Lambda: A New Addition to an Old Family
Raymond P. Donnelly et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Lambda Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal Tracts Resistant to Viral Infections
Markus Mordstein et al.
JOURNAL OF VIROLOGY (2010)
Expression of Type III Interferon (IFN) in the Vaginal Mucosa Is Mediated Primarily by Dendritic Cells and Displays Stronger Dependence on NF-κB than Type I IFNs
Marie B. Iversen et al.
JOURNAL OF VIROLOGY (2010)
The ISG15 Conjugation System Broadly Targets Newly Synthesized Proteins: Implications for the Antiviral Function of ISG15
Larissa A. Durfee et al.
MOLECULAR CELL (2010)
Clinician's guide to human papillomavirus immunology: knowns and unknowns
Mark H. Einstein et al.
LANCET INFECTIOUS DISEASES (2009)
Validation of reference genes in cervical cell samples from human papillomavirus-infected and -uninfected women for quantitative reverse transcription-PCR assays
Ibrahim I. Daud et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1
Fulvia Terenzi et al.
EMBO JOURNAL (2008)
An important role for type III interferon (IFN-λ/IL-28) in TLR-induced antiviral activity
Nina Ank et al.
JOURNAL OF IMMUNOLOGY (2008)
IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo
Caroline Sommereyns et al.
PLOS PATHOGENS (2008)
Human papillomavirus and cervical cancer
Mark Schiffman et al.
LANCET (2007)
Type III interferon (IFN) induces a type IIFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mtogen-activated protein kinases
Zhangle Zhou et al.
JOURNAL OF VIROLOGY (2007)
Interferons α and λ inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics
Tobias Marcello et al.
GASTROENTEROLOGY (2006)
Role of deficient type III interferon-λ production in asthma exacerbations
Marco Contoli et al.
NATURE MEDICINE (2006)
Direct sequencing of HPV DNA detected in. gynaecologic outpatients in Rome, Italy
Rosita Verteramo et al.
MICROBES AND INFECTION (2006)
Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo
N Ank et al.
JOURNAL OF VIROLOGY (2006)
IL-28, IL-29 and their class II cytokine receptor IL-28R
P Sheppard et al.
NATURE IMMUNOLOGY (2003)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
Share Paper
